Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
49,939,204
-
Shares change
-
+24,943,386
-
Total reported value, excl. options
-
$830,012,497
-
Value change
-
+$410,032,084
-
Put/Call ratio
-
1.1%
-
Number of buys
-
113
-
Number of sells
-
-38
-
Price
-
$16.62
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q2 2021
165 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q2 2021.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,939,204 shares
of 126,273,814 outstanding shares and own 39.55% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (7,222,127 shares), BlackRock Inc. (7,021,173 shares), STATE STREET CORP (4,244,681 shares), VANGUARD GROUP INC (2,823,624 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2,108,452 shares), MORGAN STANLEY (1,849,595 shares), NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC (1,657,440 shares), PURA VIDA INVESTMENTS, LLC (1,281,600 shares), GOLDMAN SACHS GROUP INC (1,152,423 shares), and MILLENNIUM MANAGEMENT LLC (990,447 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.